UM

Browse/Search Results:  1-6 of 6 Help

Selected(0)Clear Items/Page:    Sort:
Synthetic lethality screening identifies a potential role of Hsp90 in drug resistance of PTEN-deficient colorectal cancer Conference paper
4th Macau Symposium on Biomedical Sciences 2017
Authors:  Liu, Y.;  Yang, E.J.;  Zhang, B.;  Miao, Z.;  Wu, C.;  Lyu, J.;  Tan, K.;  Wong, K. H.;  Poon, C. W.;  Joong, S. S.
Favorite |  | TC[WOS]:0 TC[Scopus]:0 | Submit date:2022/07/27
PTEN  tumor supressor  
Selective Targeting of BRACA1 deficient breast cancer by bromodomain and extra-terminal motif (BET) inhibitors Conference paper
4th Macau Symposium on Biomedical Sciences 2017
Authors:  Zhang, B.;  Yang, E.J.;  Lyu, J.;  Liu, Y.;  Wu, C.;  Chen, Q.;  Tan, K.;  Wong, K. H.;  Xiaoling, X.;  Chuxia, D.;  Joong, S. S.
Favorite |  | TC[WOS]:0 TC[Scopus]:0 | Submit date:2022/07/27
breast cancer  BRCA1  inhibitors  
Simultaneous targeting of NPC1 and VDAC1 by itraconazole leads to synergistic inhibition of MTOR signaling and angiogenesis Journal article
ACS Chemical Biology, 2017,Volume: 12,Issue: 1,Page: 174
Authors:  Head S.A.;  Shi W.Q.;  Yang E.J.;  Nacev B.A.;  Hong S.Y.;  Pasunooti K.K.;  Li R.-J.;  Shim J.S.;  Liu J.O.
Favorite |  | TC[WOS]:49 TC[Scopus]:48 | Submit date:2018/10/30
Revisiting Non-Cancer Drugs for Cancer Therapy Journal article
Current Topics in Medicinal Chemistry, 2016,Volume: 16,Issue: 19,Page: 2144-2155
Authors:  Yang E.J.;  Wu C.;  Liu Y.;  Lv J.;  Shim J.S.
Favorite |  | TC[WOS]:12 TC[Scopus]:0 | Submit date:2019/01/15
Cancer  Disulfiram  Doxycycline  Drug Repositioning  Existing Drugs  Mebendazole  Pyrvinium Pamoate  Triclosan  
Divergence of antiangiogenic activity and hepatotoxicity of different stereoisomers of itraconazole Journal article
Clinical Cancer Research, 2016,Volume: 22,Issue: 11,Page: 2709-2720
Authors:  Shim J.S.;  Li R.-J.;  Bumpus N.N.;  Head S.A.;  Pasunooti K.K.;  Yang E.J.;  Lv J.;  Shi W.;  Liu J.O.
Favorite |  | TC[WOS]:11 TC[Scopus]:11 | Submit date:2019/01/15
Inhibition of angiogenesis by selective estrogen receptor modulators through blockade of cholesterol trafficking rather than estrogen receptor antagonism Journal article
Cancer Letters, 2015,Volume: 362,Issue: 1,Page: 106-115
Authors:  Shim J.S.;  Li R.-J.;  Lv J.;  Head S.A.;  Yang E.J.;  Liu J.O.
Favorite |  | TC[WOS]:17 TC[Scopus]:19 | Submit date:2019/01/15
Angiogenesis  Cholesterol Trafficking  Selective Estrogen Receptor Modulator  Tamoxifen